| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +40K | 6% | $0.87 | +$34.9K |
| Sells | 4 | -627K | 94% | $4.82 | -$3.02M |
| Net | 0 | -587K | -88% | -$2.99M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| 10X Fund, L.P. | 10%+ Owner | $32.6M | -$1.31M | -3.86% | Dec 2, 2025 |
| Richard E. Uihlein | Director, 10%+ Owner | $12.7M | Jan 23, 2025 | ||
| Joel Lewis | President and CEO, Director | $5.33M | -$294K | -5.23% | Nov 17, 2025 |
| James C. Czirr | 10%+ Owner | $1.03M | Feb 3, 2025 | ||
| Kevin D. Freeman | Director | $205K | +$8.13K | +4.12% | Jul 17, 2025 |
| Jack W. Callicutt | Chief Financial Officer | $163K | -$747K | -82.1% | Nov 17, 2025 |
| Kary Eldred | Director | $96.1K | +$11K | +13% | Jul 21, 2025 |
| Khurram Jamil | Chief Medical Officer | $94.1K | -$675K | -87.8% | Nov 13, 2025 |
| Pol F. Boudes | Chief Medical Officer | $71.4K | Jan 24, 2024 | ||
| Richard A. Zordani Jr. | Director | $36K | +$8.16K | +29.3% | Jan 23, 2025 |
| Harold H. Shlevin | Director | $17.6K | +$7.54K | +74.7% | Jan 23, 2025 |
| Elissa J. Schwartz | Director | Jan 23, 2025 | |||
| Gilbert F. Amelio | Director | Jan 24, 2024 | |||
| Gilbert S. Omenn | Director | Jan 23, 2025 | |||
| Benjamin Sr Carson | Director | Jan 23, 2025 | |||
| Marc Rubin | Director | Jan 23, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|